Cargando…

An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation

BACKGROUND: Hepatitis B virus (HBV) infection is one of the main causes of hepatocellular carcinoma (HCC). The relationship between HBV infection and the host genome as well as their underlying mechanisms remain largely unknown. METHODS: In this study, we performed a whole-genome exon sequencing ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bin, Han, Haijun, Zhao, Xinyi, Li, Andria N., Wang, Yan, Yuan, Wenji, Yang, Zhongli, Li, Ming D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435766/ https://www.ncbi.nlm.nih.gov/pubmed/37442062 http://dx.doi.org/10.1016/j.ebiom.2023.104694

Ejemplares similares

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Lower Somatic Mutation Levels in the λ Light-Chain Repertoires with Chronic HBV Infection
por: Hong, Binbin, et al.
Publicado: (2021)

Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
por: Zhong, L, et al.
Publicado: (2015)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

Predictive factors of response to interferon in chronic HBV hepatitis
por: Popescu, Cristina, et al.
Publicado: (2014)

Effects of Interferon-α/β on HBV Replication Determined by Viral Load
por: Tian, Yongjun, et al.
Publicado: (2011)

Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1
por: Miknis, Zachary J., et al.
Publicado: (2010)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
por: Lee, Z., et al.
Publicado: (2015)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVS
por: Luo, Zhuo, et al.
Publicado: (2020)

IFNα subtype-specific susceptibility of HBV in the course of chronic infection
por: Xie, Xiaohong, et al.
Publicado: (2022)

HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir
por: Yasutake, Yoshiaki, et al.
Publicado: (2018)

Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome
por: Liu, Changming, et al.
Publicado: (2016)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
por: Wang, Xiaomei, et al.
Publicado: (2021)

Role of STAT1 in the resistance of HBV to IFN-α
por: Xu, Bingfa, et al.
Publicado: (2021)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Anti-HBV effect of interferon-thymosin α1 recombinant proteins in transgenic Dunaliella salina in vitro and in vivo
por: Zhang, Zhihao, et al.
Publicado: (2018)

Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
por: Murata, Kazumoto, et al.
Publicado: (2018)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-γ) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population
por: Khanizadeh, Sayyad, et al.
Publicado: (2012)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Interferon stimulated immune profile changes in a humanized mouse model of HBV infection
por: Wang, Yaping, et al.
Publicado: (2023)

Haplotype‐dependent HLA‐DRB1‐DQB1 susceptibility to occult HBV infection in Xi'an Han population
por: Wang, Tianju, et al.
Publicado: (2023)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx
por: Xu, Fengchao, et al.
Publicado: (2018)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Cytokines and Chemokines in HBV Infection
por: Zhong, Shihong, et al.
Publicado: (2021)

Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
por: Jia, Wei-Dong, et al.
Publicado: (2010)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Occult HBV infection
por: Raimondo, Giovanni, et al.
Publicado: (2012)

HBV Perinatal Transmission
por: Umar, Muhammad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0qrjocu81s4gi963isagvm46vq